KIMS Closes QIP, Allots 1.98 Cr Shares at ₹755 Each, Raising Funds
Krishna Institute of Medical Sciences Limited (KIMS) closed its Qualified Institutions Placement (QIP) on June 19, 2026. The company allocated 19,867,549 equity shares at ₹755 per share, including a discount. The QIP issue opened on June 16, 2026.
The Qualified Institutions Placement (QIP) is a significant event for raising capital, which can impact the company's financial structure and future growth plans.
The company successfully completed a Qualified Institutions Placement (QIP), indicating positive investor interest and the ability to raise capital.
Krishna Institute of Medical Sciences Limited (KIMS) announced the closure of its Qualified Institutions Placement (QIP) issue on June 19, 2026. The Finance & Investment Committee of the company approved the allocation of 19,867,549 equity shares at a price of ₹755 per share. This price includes a premium of ₹753 per share and accounts for a discount of ₹16.73 per share (2.17% of the floor price).
The QIP issue, which opened on June 16, 2026, received application forms and funds from eligible qualified institutional buyers. The committee also approved the placement document dated June 19, 2026, which has been made available on the company's website. Further actions included approving the confirmation of allocation notes to be sent to successful bidders and issuing refund intimation letters to unsuccessful bidders, if any.
The meeting of the Finance & Investment Committee commenced at 6:15 PM and concluded at 7:30 PM on June 19, 2026. The company has submitted the placement document to the stock exchanges as part of its compliance with SEBI regulations.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.